Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®)
EQS Group
EQS-News: Formycon AG / Key word(s): Market Launch
Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada..